Skip to search formSkip to main contentSkip to account menu

NADPH regeneration

Known as: NADP (reduced) regeneration, reduced NADP regeneration, reduced nicotinamide adenine dinucleotide phosphate regeneration 
A metabolic process that generates a pool of NADPH by the reduction of NADP+. [GOC:mah]
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The ethanol synthesis pathway engineered Synechocystis sp. PCC 6803 (hereafter Synechocystis) was used to investigate the… 
2017
2017
To characterize a recombinant carbonyl reductase from Saccharomyces cerevisiae (SceCPR1) and explore its use in asymmetric… 
2015
2015
NADPH regeneration capacity is attracting growing research attention due to its important role in resisting oxidative stress… 
2011
2011
........................................................................................................................................... 11 CHAPTER I ......................................................................................................................................... 13 General Introduction ........................................................................................................................ 14 1. Non native invasive species ................................................................................................. 14 1.1. Corbicula fluminea ................................................................................................................. 16 2. Anthropogenic contamination ............................................................................................. 17 2.1 Polycyclic aromatic hydrocarbons .......................................................................................... 19 2.2. Benzo[a]pyrene ....................................................................................................................... 20 3. Environmental biomarkers ................................................................................................... 23 3.1. Phase I ..................................................................................................................................... 25 3.2. Phase II .................................................................................................................................... 25 3.3. Biomarkers .............................................................................................................................. 26 4. Objectives ............................................................................................................................. 30 5. Thesis Structure .................................................................................................................... 30 6. References ............................................................................................................................ 31 CHAPTER II ........................................................................................................................................ 39 Abstract ............................................................................................................................................... 41.............................................................................................................................................. 41 
2004
2004
AbstractTwo recombinant strains, E. coli M15 (pQE30-alr0307) and E. coli M15 (pQE30-gdh0310), which were constructed to express…